Reeve Emma 4
4 · PTC THERAPEUTICS, INC. · Filed Nov 14, 2025
Insider Transaction Report
Form 4
Reeve Emma
Director
Transactions
- Sale
Common Stock
2025-11-12$74.50/sh−7,333$546,309→ 6,666 total - Exercise/Conversion
Common Stock
2025-11-12$46.54/sh+7,333$341,278→ 13,999 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-11-12−7,333→ 1,467 totalExercise: $46.54Exp: 2035-01-02→ Common Stock (7,333 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.
- [F2]This option was granted on January 3, 2025 and vests over one year in twelve equal monthly installments, commencing on February 3, 2025.